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Abstract: To improve integration of a biomaterial with surrounding tissue, its surface properties 16 
may be modified by adsorption of biomacromolecules, e.g. fibrils. Whey protein isolate (WPI), a 17 
dairy industry by-product, supports osteoblastic cell growth. WPI’s main component, β-18 
lactoglobulin, forms fibrils in acidic solutions. In this study, aiming to develop coatings for 19 
biomaterials for bone contact, substrates were coated with WPI fibrils obtained at pH 2 or 3.5. 20 
Importantly, WPI fibrils coatings withstood autoclave sterilization and appeared to promote human 21 
bone marrow stromal cells (hBMSC) spreading and differentiation. In the future, WPI fibrils 22 
coatings could facilitate immobilization of biomolecules with growth stimulating or antimicrobial 23 
properties. 24 
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1. Introduction 27 
Whey protein isolate (WPI) is a dairy industry by-product which contains > 95% protein, of 28 
which 75% is β-lactoglobulin [1]. Previous studies showed that WPI enhances cell proliferation and 29 
osteogenic differentiation and displays antibacterial properties [1–3]. Upon heating under acidic 30 
conditions, β-lactoglobulin degrades into smaller peptides which undergo self-assembly to form 31 
fibrils several micrometers long and a few nm thick [4], whose morphology is pH-dependent (long 32 
semi-flexible fibers at pH 2, worm-like structures at pH 3.5) [5–7]. 33 
Better cell-biomaterial interactions, and biomaterial integration into host tissue can be achieved 34 
by improving surface properties, e.g. by coatings. Fibrillar coatings have advantages including high 35 
surface/volume ratio, promoting fibril adhesion to substrates. Biologically active molecules can be 36 
immobilized on fibrils [8,9], which can form aligned superstructure scaffolds [10], improve cell line 37 
attachment and act as biomimetic cell culture platforms [11–13].  38 
A commonly used fibrillar molecule used as implant coating materials is collagen, which is 39 
known to promote cell adhesion, spreading and proliferation [14–18]. Fibronectin is another 40 
commonly used molecule to improve cell adhesion, also in fibrillar form [19,20]. One advantage of 41 
WPI is its low cost, as it is a by-product of the dairy industry. 42 
With the intention of developing coatings for biomaterials for bone contact, WPI fibrillar 43 
coatings were formed to support and enhance spreading, attachment and differentiation of hBMSC, 44 
which have greater clinical relevance than cell lines. WPI fibrils were hypothesized to withstand 45 
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autoclaving as WPI hydrogels do [21]. Autoclaving was preferred due to its ubiquity, clinical 46 
acceptance and low cost. 47 
WPI fibrils were formed in solutions at two different pH values, 2 and 3.5. A WPI solution 48 
concentration of 2.5 wt% was used. WPI concentrations between 2.5 % and 5 % WPI were found to 49 
result in a high fibril yield [3,4], and especially 2.5 % WPI is often used in WPI or beta-Lactoglobulin 50 
fibril studies due to the lower sample viscosity which improves handling. Because the protein 51 
concentration also affects the aggregation kinetics and morphology of the resulting aggregates [22–52 
24], deviations from these ideal values can also reduce the comparability to other studies. and then 53 
adsorbed onto substrates and imaged by Scanning Electron Microscopy (SEM). Finally, autoclaved 54 
coatings were characterized using hBMSC. 55 
 56 
2. Results and discussion 57 
WPI fibril formation (shown schematically in Figure 1a) was influenced by pH, as measurements 58 
of fibrillar yield at pH 2 (approximately 25%) and pH 3.5 (> 40%) demonstrated (Figure 1b). Similar 59 
observations were reported previously [5–7]. Differences in yield are attributed to differences in the 60 
fibril building blocks, which are specific acid hydrolysed peptides at pH 2 [4], but unspecific non-61 
hydrolyzed proteins at pH 3.5 [5]. 62 
 63 
 64 
Figure 1. (a) Process of fibrils formation at pH 2 in solution; at pH 2, β-lactoglobulin denatures and 65 
hydrolyses at 90°C. Specific peptides self-associate into the amyloid aggregates, which can consist of 66 
approximately three intertwined protofibrils. At pH 3.5, acid hydrolysis is reduced; therefore non-67 
hydrolyzed β-lactoglobulin assembles into worm-like aggregates, which are not amyloid but 68 
amyloid-like and of different shape and morphology than at pH. (b) Fibrillar yield in solutions of 69 
different pH and (c) adsorption of WPI fibrils on glass substrates. 70 
 71 
Contact angle (CA) measurements demonstrated a significant increase from 20 to approximately 72 
55° on both coated sample types (Figure 2a). Similar increases were reported for edible WPI fibril 73 
coatings on fruits [25]. Advantageously for cell growth, CA remains lower than 100° [26]. A 74 
hydrophilic surface is beneficial for cell adhesion to make sure that proteins from cell culture medium 75 
adsorb to the surface in the desired conformation, so that binding sites on the proteins are recognized 76 
by the cells. Furthermore, a lower contact angle and higher wettability would facilitate coating of 77 
rough or porous biomaterial surfaces. 78 
SEM images confirmed that fibril coatings withstood washing and drying. Fibrils prepared at 79 
pH 3.5 (Figure 2c) appeared to be shorter and less straight than those formed at pH 2 (Figure 2b), in 80 
agreement with previous studies [5]. Fibrils were detected by SEM after autoclaving (supplementary 81 
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information, figure S1); hence, they withstand sterilization. Adhesion of the fibrils to substrates 82 
would hinder fibril aggregation and degradation as in previous studies [27,28]; hence the coating is 83 
estimated to be one fibril thick. 84 
 85 
Figure 2. (a) CA measurements of uncoated and fibrillar coated samples with solution at pH 2 and 86 
pH 3.5 and SEM images of fibrillar coatings obtained at (b) pH 2 and (c) pH 3.5 (scale bar: 1 μm) 87 
 88 
Adhesion of hBMSC was confirmed on the uncoated (Figure 3a) and coated samples 89 
(Figure 3b,c). Spreading was superior and tissue non-specific alkaline phosphatase (TNAP) activity 90 
(a marker of osteogenic differentiation and linked to the calcium deposition as shown previously 91 
[9,29]) was higher on coated samples (Figure 3g). The cells became confluent over the WPI coatings.   92 
hBMSC on coated samples showed 2 h after seeding clear focal adhesion contacts and a well-93 
organized cytoskeleton. A possible reason for that could be that diverse proteins from the serum and 94 
cellular in situ-formed proteins adsorbed on the WPI layer and thus promoted initial adhesion. The 95 
cell number on coated samples at day 2 and day 4 after seeding (MTS formazan formation is a 96 
measure of cell number and can be used as an index of cell proliferation) did not differ substantially 97 
from that on glass. 98 
For hBMSC, proper adhesion, spreading and re-organization of cytoskeleton is an essential 99 
prerequisite for proliferation and differentiation of the cells. The fibrillar coating promoted the 100 
adhesion and re-organization of the cytoskeleton of hBMSC, did not influence the number of 101 
adherent cells, but obviously improved their “quality” as evidenced by higher TNAP activity.  102 
Hence, we suspect that the coatings induced a superior start of the differentiation program of 103 
cells. Analysis concerning the molecular mechanisms are planned for future studies. In the present 104 
study, we wished to ascertain whether such a fibrillar coating has advantages for hBMSC adhesion 105 
and promotes osteogenic parameters. 106 
Apparently differences in yields and morphologies of straight fibrils observed at pH 2 and the 107 
worm-like aggregates observed at pH 3.5 do not affect hBMSC. hBMSC metabolic activity increased 108 
slightly from day 2 to 4 (Figure 3h,i), but not significantly. 109 
 110 
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 111 
Figure 3. (a) Morphology of hBMSC on (a) glass, (b) fibrillar coating (pH=2), (c) fibrillar coating 112 
(pH=3.5), 2 h after plating, and (d), (e), (f) TNAP staining at day 11 after plating, respectively. (g) 113 
TNAP activity on different substrates (day 11) and metabolic activity results at (h) day 2 and (i) day 114 
4 after plating. 115 
Future work will focus on preparation of coatings from fibrils obtained at other pH values. It is 116 
well known that the typical fibrils with amyloid structure only occur at pH 2, while worm-like 117 
aggregates can be observed at pH 3.5 [6]. Spherical aggregates emerge at pH 4 to 5 [7] and otherwise 118 
there are also smaller aggregates observed at neutral pH. Besides pH-induced changes, the addition 119 
of sodium chloride or the protein concentration can affect the morphology, as well as addition of 120 
solvents [22,30]. The structures have different yields (i.e., portion of amyloid to non-assembled 121 
material) but also different processing stabilities. Thus, there is a whole range of conditions that can 122 
be used to alter the morphology and to study the correlation between structure and cell behaviour in 123 
the future.  124 
Another focus of future work will be extension of the cell biological characterization of the 125 
coatings to elucidate the exact mechanism by which coatings may promote differentiation and to 126 
include cell-induced mineralization. From previous investigations, it is known that an increase of 127 
TNAP activity leads to an increase in released phosphate ions into the conditioned medium and in 128 
consequence to enhanced mineralization [9], which should be studied in future. 129 
WPI fibrillar coatings can be enhanced by incorporation of molecules with growth-stimulatory 130 
or antimicrobial properties into the coatings, coating thickness and mechanical measurements and 131 
substrates more appropriate for bone contact (e.g. titanium alloy). Furthermore, WPI fibrillar coatings 132 
should be compared to more commonly used fibrillar coatings of fibronectin and collagen, which are 133 
known to promote cell adhesion [14–20].  134 
 135 
4. Materials and Methods  136 
WPI (BiPro, Davisco Foods International Inc., USA) was dissolved in Milli-Q (2.5 wt%). pH was 137 
set to 2 and 3.5 by adding HCl. 15 mL WPI solution was heated (90°C. 5h, stirring speed 350 rpm) to 138 
induce fibril formation resulting in a fibrillar suspension. Glass substrates (chosen as an inexpensive 139 
substrate for this pilot study) were coated with fibrils by adsorption from the suspension. Substrates 140 
were rinsed with Milli-Q to remove non-adhered fibrils, air-dried and autoclaved (121°C, 15 141 
minutes). SEM, CA measurements and fibrillar yield quantification were performed as described 142 
previously [5,7,31,32]. 143 
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hBMSC were isolated from bone marrow aspirates from donors (males, average 27 ± 5 yrs.) who 144 
gave full informed consent (local ethics commission (ethic vote No. EK466112016)), at the Bone 145 
Marrow Transplantation Center, University Hospital Dresden, characterized and plated onto 146 
samples (5,555 hBMSC/cm2) as described previously [29,33]. 147 
After 2h, hBMSC morphology was monitored by fluorescence staining of F-actin and 148 
phosphorylated focal adhesion kinase, as described previously [8]. Metabolic activity of hBMSC was 149 
determined by the standard MTS assay (Cell Titer96 AQueous One Solution Proliferation Assay) 150 
(Promega, Mannheim, Germany). Cell culture medium was replaced by fresh medium containing 151 
10% of MTS dye solution. After incubation in a humidified CO2 incubator (2h, 37°C), 80 μL medium 152 
was removed and absorbance was measured photometrically at 490 nm.  153 
At day 11 after seeding hBMSC were stained for tissue non-specific alkaline phosphatase 154 
(TNAP) enzyme activity with a commercial staining kit (86-R, Sigma). Images were obtained and 155 
TNAP enzyme activity was determined, as described previously [8]. 156 
Experiments were performed with cells from three different donors (n=3) each in triplicate. 157 
Results are presented as mean ± standard error of the mean. Statistical significance was analysed with 158 
GraphPad Prism 8.4 software (Statcon, Witzenhausen, Germany) by ANOVA analysis with 159 
Bonferroni’s post-test. 160 
 161 
5. Conclusions 162 
Formation of WPI fibrils in solution was strongly pH-dependant; fibrillar yield increased when 163 
pH was increased from 2 to 3.5. WPI fibrillar coatings resisted autoclave sterilization and supported 164 
the attachment, spreading and differentiation of hBMSC. The pH 2 and pH 3.5 fibrils had an equally 165 
positive effect on cell differentiation.  166 
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TNAP Tissue non-specific alkaline phosphatase 
WPI Whey protein isolate 
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